Evidence map›Paper›PMID 42058245›Full record

ArticleArchives of Razi Institute2025

The Antimicrobial and Antibiofilm Potential of

Osanloo Mahmoud, Alipanah Hiva, Hashempour Mohammad Arman, Motazedian Benyamin, Zarenezhad Elham, Zahedifard Zahra, Ghasemian Abdolmajid

Abstract read
In one paragraph

Article in Archives of Razi Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Osanloo MahmoudDepartment of Medical Nanotechnology, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Alipanah HivaDepartment of Physiology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Hashempour Mohammad ArmanDepartment of Medicine, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Motazedian BenyaminDepartment of Medicine, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Zarenezhad ElhamNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Zahedifard ZahraDepartment of Medical Biotechnology, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Ghasemian AbdolmajidNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance has posed considerable health and economic burdens globally (approximately five million deaths annually), particularly in developing countries. The estimated annual treatment costs in the United States include US$4.6 billion. Vast antibiotic resistance among Gram-negative and Gram-positive bacterial species has spread from healthcare to the environment, community, and animals. These conditions have limited and in some cases, failed infection eradication options and facilitated the distribution of drug-resistant organisms. The spread of drug-resistant bacterial infections is a major human health concern, hence, seeking novel antibacterial agents is crucial. This study used nanoemulsions of

Indexed as

Anti-Bacterial AgentsArtemisia annuaBiofilmsCitrusOils, VolatilePlant OilsEmulsionsMicrobial Sensitivity TestsAnti-Bacterial AgentsEmulsionsOils, VolatilePlant OilsAntibacterial AgentsEssential OilPhytochemicalsReactive Oxygen Species

Identifiers

PMID42058245
PMCPMC13122419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.